Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RxSight, Inc. - Common Stock (NQ: RXST )

32.05 +0.16 (+0.49%)
Streaming Delayed Price Updated: 3:23 PM EST, Feb 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 261,063
Open 32.08
Bid (Size) 32.03 (8)
Ask (Size) 32.08 (1)
Prev. Close 31.90
Today's Range 31.65 - 32.16
52wk Range 26.29 - 66.54
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance
From RxSight, Inc.
Via GlobeNewswire

Performance

YTD
-7.22%
-7.22%
1 Month
+4.35%
+4.35%
3 Month
-28.21%
-28.21%
6 Month
-37.27%
-37.27%
1 Year
-36.66%
-36.66%

More News

Read More
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
From RxSight, Inc.
Via GlobeNewswire
Forecasting The Future: 4 Analyst Projections For RxSight
Via Benzinga
Analyst Scoreboard: 7 Ratings For RxSight
Via Benzinga
Peeling Back The Layers: Exploring RxSight Through Analyst Insights
Via Benzinga
Deep Dive Into RxSight Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
This Nike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
RxSight, Inc. Reports Third Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
This Six Flags Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
RxSight Analysts Slash Their Forecasts After Q2 Results
Via Benzinga
RXST Stock Earnings: RxSight Beats Revenue for Q2 2024
Via InvestorPlace
RxSight Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024
From RxSight, Inc.
Via GlobeNewswire
RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences
From RxSight, Inc.
Via GlobeNewswire
RxSight Stock Sees Relative Strength Rating Rise To 91
Via Investor's Business Daily
Lithia Motors To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
RxSight, Inc. Reports Second Quarter 2024 Financial Results
From RxSight, Inc.
Via GlobeNewswire
The 3 Best Med Tech Stocks to Buy Now
Via InvestorPlace
RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
From RxSight, Inc.
Via GlobeNewswire
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Via Benzinga
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.